Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pakistan Blocks Import Of Competing Drugs From India

This article was originally published in PharmAsia News

Executive Summary

The government of Pakistan has canceled plans to allow 400 drugs to be imported from India, apparently giving in to the nearly $2 billion Pakistan drug industry. Pakistan's Commerce Ministry had planned the imports to forestall a large increase in the prices of life-saving drugs, in some cases by as much as 40 percent. Pakistan's new prime minister reportedly issued orders blocking importation of any drugs that would compete with Pakistani-made drugs and demanded justification for proposals to import 13 vaccines and some cancer drugs not produced in Pakistan. (Click here for more
UsernamePublicRestriction

Register

SC069069

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel